30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: Integra LifeSciences

Orthopaedic revenue $79.5MM, +5%

  • U.S. Extremities $43.4MM, +8% (includes skin and wound repair products)
  • U.S. Spine & Other $45.0MM, +4% (U.S. Spine flat; Private Label $14.1MM)


  • Growth buoyed by shoulder product launch, expected to be large contributor to 2H: expanded customer base through new distribution
  • Launched Freedom Wrist and TFS2 lower foot system
  • Lost share in lower extremities hardware due to sales turnover (now mostly replaced); line refresh is in progress
  • Premier GPO contract for small bone implants generating access to top IDN systems in their network